Table 2.
Liver graft HSC total and zonal activation according to the presence and the predominant type of steatosis.
| Nil Steatosis |
Pred. Sd-MaS |
Pred. Ld-MaS |
p-Value |
p-Value Pred. Ld-Mas vs. Pred. Sd-Mas |
p-Value Pred. Ld-Mas vs. Nil Steatosis |
p-Value Pred. Sd-Mas vs. Nil Steatosis |
|
|---|---|---|---|---|---|---|---|
| n | 22 | 12 | 29 | ||||
| Lobular HSC | 4.00 (1.88–7.00) |
2.00 (1.00–4.00) |
4.50 (3.50–5.75) |
0.041 | 0.036 | >0.999 | 0.228 |
| Acinar zone 1 HSC | 1.00 (0.50–1.00) |
0.50 (0.50–1.00) |
1.00 (0.50–1.50) |
0.204 | - | - | - |
| Acinar zone 2 HSC | 2.00 (0.50–3.00) |
0.75 (0.00–2.00) |
2.00 (1.50–2.50) |
0.041 | 0.035 | 0.980 | 0.303 |
| Acinar zone 3 HSC | 1.50 (0.50–2.25) |
0.75 (0.50–1.00) |
2.00 (1.00–2.00) |
0.043 | 0.037 | >0.999 | 0.258 |
Data are expressed as median and interquartile range. Pred. Ld-MaS: predominant large droplet macrovescicular steatosis; Pred. Sd-MaS: predominant small droplet macrovescicular steatosis. HSC: hepatic stellate cell. p-values numbers marked in bold indicate numbers that are significant at the p < 0.05 level.